Eli Lilly and Company Clinical Trials
Sponsors / Eli Lilly and Company
Eli Lilly and Company appears as lead sponsor on 2,264 trial records in ClinicalTrials.gov. The portfolio currently includes 148 recruiting studies, 128 active non-recruiting studies, and 1760 completed studies. 169 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include efficacy or futility findings, slow or insufficient recruitment. Cumulative planned enrollment across all listed trials is 1,089,129 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
2,264
Total Trials
148
Recruiting
128
Other Active
1,760
Completed
169
Terminated / Withdrawn
1,089,129
Total Enrollment
Termination reasons: Other31% · Efficacy29% · Recruitment15% · Safety12% · Business9% · Funding2% · Regulatory1%
Recent Terminations
- Healthy"Study terminated for strategic business reasons"
- Obesity"Study terminated for strategic business reasons"
- Atopic Dermatitis"The decision to terminate the study was due to efficacy/effectiveness reasons."
- Dyslipidemias"Participants were not dosed in Part B as per the protocol, the patient population will be refined and new outcome measures will be applied in a separate study."
- Heart Failure"An interim was conducted and after review of available data, including efficacy evaluation of heart failure events, Lilly is terminating the study due to low likelihood of study success for this HFpEF patient population."
- Arthritis"Study terminated due to an unfavourable benefit-risk profile observed in interim data analysis."
- Atopic Dermatitis"The study was terminated for lack of efficacy."
- Atopic Dermatitis"Based on emerging nonclinical data, the study was terminated."
- Hypertriglyceridemia"The study was terminated due to a change in risk/benefit ratio, which no longer favoured continued development."
- Healthy"Following preplanned review of the safety and pharmacokinetic data from Part A, it was determined that sufficient data had been obtained. The decision was made to not proceed with Part B and the study was terminated early."
Active Trials (128 total)
- NCT04408625
- NCT07286175
- NCT05501704
- NCT07511816
- NCT06568042
- NCT07174336
- NCT06972459
- NCT06993792
- NCT07533006
- NCT07533019
- NCT07169851
- NCT07269210
- NCT05768139
- NCT05848258
- NCT07420283
- NCT04521686
- NCT06607185
- NCT07415044
- NCT04106219
- NCT04844606